Holdings of Fidelity Advisor Health Care Fund
Fidelity Advisor Series VII · 104 declared positions · as of Apr 30, 2026
Original filing · Net assets 2.9B $ · Ten largest lines: 39.8 % of the equity sleeve
Sector breakdown
- Health care 44.1 %
- Unattributed 55.9 %
Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.
Currency breakdown
- USD 96.9 %
- EUR 2.1 %
- CHF 0.9 %
The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.
Country breakdown
- US 90.3 %
- NL 2.7 %
- BE 2.1 %
- CA 1.2 %
- KY 1.0 %
- BM 1.0 %
- CH 0.9 %
- IE 0.7 %
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 94 | 2.5B $ | 90.32 % |
| NL | 3 | 76.3M $ | 2.73 % |
| BE | 1 | 59.2M $ | 2.12 % |
| CA | 1 | 33.6M $ | 1.20 % |
| KY | 1 | 27.3M $ | 0.98 % |
| BM | 2 | 27M $ | 0.97 % |
| CH | 1 | 26.5M $ | 0.95 % |
| IE | 1 | 20.3M $ | 0.73 % |
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| Eli Lilly & Co | 214,000 | 200M $ | 6.93 % |
| Danaher Corp | 1,095,000 | 196M $ | 6.79 % |
| Johnson & Johnson | 712,000 | 163.7M $ | 5.67 % |
| Thermo Fisher Scientific Inc | 218,000 | 104.4M $ | 3.62 % |
| UnitedHealth Group Inc | 235,000 | 87.1M $ | 3.02 % |
| Boston Scientific Corp | 1,400,000 | 80.7M $ | 2.79 % |
| Ascendis Pharma A/S | 340,000 | 78M $ | 2.70 % |
| Alnylam Pharmaceuticals Inc | 228,000 | 70.6M $ | 2.44 % |
| Gilead Sciences Inc | 500,000 | 65.4M $ | 2.27 % |
| AbbVie Inc | 304,000 | 64.2M $ | 2.23 % |
| UCB SA | 218,000 | 59.2M $ | 2.05 % |
| Argenx SE | 65,000 | 50.8M $ | 1.76 % |
| BrightSpring Health Services Inc | 1,000,000 | 48M $ | 1.66 % |
| Cencora Inc | 143,500 | 44.2M $ | 1.53 % |
| Merck & Co Inc | 400,000 | 43.7M $ | 1.51 % |
| Insmed Inc | 318,000 | 43.4M $ | 1.50 % |
| Edwards Lifesciences Corp | 500,000 | 41.8M $ | 1.45 % |
| Nuvalent Inc | 360,000 | 36.1M $ | 1.25 % |
| CVS Health Corp | 428,000 | 35.6M $ | 1.23 % |
| Moderna Inc | 760,000 | 34.9M $ | 1.21 % |
| Cogent Biosciences Inc | 960,000 | 34.4M $ | 1.19 % |
| Caris Life Sciences Inc | 1,800,000 | 34.2M $ | 1.18 % |
| Xenon Pharmaceuticals Inc | 600,000 | 33.6M $ | 1.16 % |
| Vaxcyte Inc | 540,000 | 30.9M $ | 1.07 % |
| Spyre Therapeutics Inc | 410,000 | 30.5M $ | 1.06 % |
| Royalty Pharma PLC | 590,000 | 29.6M $ | 1.02 % |
| Privia Health Group Inc | 1,180,000 | 29.3M $ | 1.02 % |
| Oruka Therapeutics Inc | 424,000 | 29M $ | 1.00 % |
| Bio-Techne Corp | 500,000 | 27.7M $ | 0.96 % |
| Medline Inc | 620,000 | 27.6M $ | 0.96 % |
| Viatris Inc | 1,834,609 | 27.4M $ | 0.95 % |
| LEGEND BIOTECH CORP | 1,160,000 | 27.3M $ | 0.95 % |
| Roche Holding AG | 65,000 | 26.5M $ | 0.92 % |
| Crinetics Pharmaceuticals Inc | 670,000 | 26M $ | 0.90 % |
| Natera Inc | 126,000 | 26M $ | 0.90 % |
| Repligen Corp | 215,000 | 25.4M $ | 0.88 % |
| Alignment Healthcare Inc | 1,080,000 | 24.3M $ | 0.84 % |
| Enliven Therapeutics Inc | 580,000 | 23.9M $ | 0.83 % |
| West Pharmaceutical Services Inc | 80,000 | 23.8M $ | 0.82 % |
| Axsome Therapeutics Inc | 112,000 | 23.3M $ | 0.81 % |
| Disc Medicine Inc | 345,000 | 22.8M $ | 0.79 % |
| Veracyte Inc | 670,000 | 22.1M $ | 0.76 % |
| Kiniksa Pharmaceuticals International Plc | 400,000 | 21.5M $ | 0.75 % |
| 10X Genomics Inc | 950,000 | 20.9M $ | 0.73 % |
| Jazz Pharmaceuticals PLC | 100,000 | 20.3M $ | 0.70 % |
| Intuitive Surgical Inc | 43,500 | 19.9M $ | 0.69 % |
| LifeStance Health Group Inc | 2,500,000 | 18.9M $ | 0.66 % |
| CG oncology Inc | 280,000 | 18.7M $ | 0.65 % |
| Tenet Healthcare Corp | 105,000 | 18.6M $ | 0.64 % |
| Guardant Health Inc | 210,000 | 18.3M $ | 0.63 % |
| Roivant Sciences Ltd | 640,000 | 18.3M $ | 0.63 % |
| Kymera Therapeutics Inc | 225,000 | 18.2M $ | 0.63 % |
| Praxis Precision Medicines Inc | 53,000 | 16.9M $ | 0.59 % |
| Insulet Corp | 98,000 | 16.9M $ | 0.58 % |
| Mineralys Therapeutics Inc | 600,000 | 16M $ | 0.55 % |
| Pharvaris NV | 500,000 | 15.5M $ | 0.54 % |
| HeartFlow Inc | 500,000 | 14.9M $ | 0.52 % |
| Revolution Medicines Inc | 100,000 | 14.4M $ | 0.50 % |
| Bruker Corp | 380,000 | 13.9M $ | 0.48 % |
| Cytokinetics Inc | 218,000 | 13.9M $ | 0.48 % |
| BEONE MEDICINES LTD | 46,000 | 13.6M $ | 0.47 % |
| Veeva Systems Inc | 86,000 | 13.4M $ | 0.46 % |
| McKesson Corp | 16,000 | 13M $ | 0.45 % |
| Travere Therapeutics Inc | 290,000 | 12.2M $ | 0.42 % |
| Structure Therapeutics Inc | 280,000 | 11.6M $ | 0.40 % |
| Viridian Therapeutics Inc | 860,000 | 11.6M $ | 0.40 % |
| Waystar Holding Corp | 540,000 | 11.5M $ | 0.40 % |
| Amylyx Pharmaceuticals Inc | 715,000 | 11.4M $ | 0.40 % |
| IRhythm Holdings Inc | 85,000 | 11M $ | 0.38 % |
| Olema Pharmaceuticals Inc | 750,000 | 10.8M $ | 0.37 % |
| Stoke Therapeutics Inc | 330,000 | 10.8M $ | 0.37 % |
| CytomX Therapeutics Inc | 2,500,000 | 10.6M $ | 0.37 % |
| Newamsterdam Pharma Co NV | 350,000 | 10M $ | 0.35 % |
| Mirum Pharmaceuticals Inc | 100,000 | 9.7M $ | 0.34 % |
| ZENAS BIOPHARMA INC | 500,000 | 9.7M $ | 0.33 % |
| MBX Biosciences Inc | 300,000 | 9.1M $ | 0.31 % |
| Viking Therapeutics Inc | 280,000 | 8.7M $ | 0.30 % |
| Kestra Medical Technologies Ltd | 420,000 | 8.7M $ | 0.30 % |
| Summit Therapeutics Inc | 400,000 | 8.6M $ | 0.30 % |
| Elevance Health Inc | 21,000 | 7.9M $ | 0.27 % |
| Dianthus Therapeutics Inc | 85,000 | 7.5M $ | 0.26 % |
| Scholar Rock Holding Corp | 160,000 | 7.5M $ | 0.26 % |
| Immunocore Holdings PLC | 260,000 | 7.3M $ | 0.25 % |
| Stryker Corp | 22,800 | 7.2M $ | 0.25 % |
| DAMORA THERAPEUTICS INC | 280,000 | 7.2M $ | 0.25 % |
| Trevi Therapeutics Inc | 500,000 | 6.9M $ | 0.24 % |
| JADE BIOSCIENCES INC | 280,000 | 6.8M $ | 0.24 % |
| Relay Therapeutics Inc | 500,000 | 6.5M $ | 0.22 % |
| VeraDermics Inc | 60,000 | 5.9M $ | 0.21 % |
| Biogen Inc | 28,000 | 5.3M $ | 0.18 % |
| Tyra Biosciences Inc | 140,000 | 4.9M $ | 0.17 % |
| Apogee Therapeutics Inc | 55,316 | 4.6M $ | 0.16 % |
| Annexon Inc | 750,000 | 4.4M $ | 0.15 % |
| Alamar Biosciences Inc | 168,000 | 4.2M $ | 0.15 % |
| Shoulder Innovations Inc | 310,692 | 4M $ | 0.14 % |
| Alumis Inc | 150,700 | 3.7M $ | 0.13 % |
| Upstream Bio Inc | 400,000 | 3.7M $ | 0.13 % |
| Contineum Therapeutics Inc | 280,000 | 3.6M $ | 0.12 % |
| Outset Medical Inc | 800,000 | 3.4M $ | 0.12 % |
| Ocular Therapeutix Inc | 277,371 | 2.6M $ | 0.09 % |
| Immunome Inc | 33,871 | 777K $ | 0.03 % |
| SALUDA MEDICAL INC | 966,580 | 419.4K $ | 0.01 % |
| Acumen Pharmaceuticals Inc | 84,427 | 201.8K $ | 0.01 % |
| CYCLERION THERAPEUTICS INC | 1,500 | 5K $ | 0.00 % |